THAR logo

Tharimmune, Inc. Stock Price

NasdaqCM:THAR Community·US$177.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

THAR Share Price Performance

US$4.48
2.59 (137.04%)
US$4.48
2.59 (137.04%)
Price US$4.48

THAR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

Tharimmune, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$10.3m

Other Expenses

-US$10.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.26
0%
0%
3.2%
View Full Analysis

About THAR

Founded
2017
Employees
3
CEO
Mark Wendland
WebsiteView website
www.tharimmune.com

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.

Recent THAR News & Updates

Recent updates

No updates